Factors associated with non-participation in and dropout from cardiac rehabilitation programmes: a systematic review of prospective cohort studies

Autor: Resurrección DM, Moreno-Peral P, Gómez-Herranz M, Rubio-Valera M, Pastor L, Caldas de Almeida JM, Motrico E

Publikováno v: EUROPEAN JOURNAL OF CARDIOVASCULAR NURSING
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
instname
r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Fundació Sant Joan de Déu

BACKGROUND: Although evidence exists for the efficacy of cardiac rehabilitation programmes to reduce morbidity and mortality among patients with cardiovascular disease, cardiac rehabilitation programmes are underused. We aimed systematically to revie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::ba2808bb65f42fc3aae9b43b4d37c02d
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=16021

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional Regulation.

Autor: O'Neill JR; Cambridge Oesophagogastric Centre, Addenbrooke's Hospital, Cambridge, United Kingdom; Institute of Genetics and Cancer (IGC), University of Edinburgh, Edinburgh, Scotland. Electronic address: robertoneill@nhs.net., Yébenes Mayordomo M; Institute of Genetics and Cancer (IGC), University of Edinburgh, Edinburgh, Scotland; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland. Electronic address: marcos.yebenes@gmail.com., Mitulović G; Clinical Department of Laboratory Medicine Proteomics Core Facility, Medical University Vienna, Vienna, Austria; Bruker Austria, Wien, Austria., Al Shboul S; Department of Pharmacology and Public Health, Faculty of Medicine, The Hashemite University, Zarqa, Jordan., Bedran G; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland., Faktor J; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland., Hernychova L; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Uhrik L; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Gómez-Herranz M; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland., Kocikowski M; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland., Save V; Department of Pathology, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom., Vojtěšek B; Research Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic., Arends MJ; Edinburgh Pathology, Institute of Genetics and Cancer (IGC), University of Edinburgh, Edinburgh, Scotland., Hupp T; Institute of Genetics and Cancer (IGC), University of Edinburgh, Edinburgh, Scotland; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland., Alfaro JA; International Center for Cancer Vaccine Science (ICCVS), University of Gdansk, Gdansk, Poland; Institute for Adaptive and Neural Computation, School of Informatics, University of Edinburgh, Edinburgh, UK; International Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland; Department of Biochemistry and Microbiology, University of Victoria, Victoria, Canada; The Canadian Association for Responsible AI in Medicine, Victoria, BC, Canada. Electronic address: Javier.alfaro@proteogenomics.ca.

Publikováno v: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2024 Jun; Vol. 23 (6), pp. 100764. Date of Electronic Publication: 2024 Apr 09.